Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

D Sandford Smith

Affiliations

  • Director at Cytokinetics Inc (CYTK), 2020-05-14
  • Director at Akcea Therapeutics Inc. (AKCA), 2020-04-15
  • Director at Neuralstem Inc. (CUR), 2019-07-03
  • Director at Apricus Biosciences Inc. (APRI), 2018-01-08
  • Director at Novelion Therapeutics Inc. (NVLN), 2017-02-03
  • Director at Aegerion Pharmaceuticals Inc. (AEGR), 2016-12-01
  • Exe Vp,president Int'l Group at Genzyme Corp (GENZ), 2011-04-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
APRI $1.59 18,200 Director 26,500 2014-10-23 Filing
APRI $1.52 8,300 Director 8,300 2014-10-22 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AEGR $95.00 2,502 Director 0 2013-10-29 Filing
AEGR $92.25 1,537 Director 0 2013-08-12 Filing
AEGR $92.33 8,463 Director 1,537 2013-08-09 Filing
GENZ $63.75 20,741 Officer 20,671 2010-07-23 Filing
GENZ $66.10 9,000 Officer 41,412 2010-07-23 Filing